By 2020, the Senate will have to decide whether to reauthorize the COVID-19 vaccine, which is the only vaccine in existence to prevent coronavirus and other diseases caused by the coronaviruses coronaviral and respiratory viruses.
The vaccine, developed by Pfizer and manufactured by Pfiser, has been available since the end of December, and the Senate has not approved a budget to re-authorize it.
The Senate will only have until March 15 to pass the legislation.
The Senate is set to take up the bill, which was approved by the Senate on Monday, when the majority of Democrats will vote for it, with a simple majority needed to pass.
The majority of Republicans will vote against it.
It is unlikely that any of the Republican-controlled committees in the Senate, including the Environment and Public Works Committee, which oversees vaccine development, will be able to get a vote on the bill.
The majority Republicans on the Environment Committee, including Environment Subcommittee Chairman Rob Portman, will not vote to approve the bill either.
On the Environment Subcommittee, the majority Republican, Representative Michael Burgess of Texas, will oppose the bill on the grounds that it does not include a requirement that states provide the vaccine to their residents.
But he will support a motion by Democrats to make it a condition of reauthorization that the Senate not reauthorizes the vaccine until 2019.
Republicans in the House are set to vote on a bill to reestablish COVID vaccines at the end on March 11.
However, a final vote will be postponed until the day of the US presidential election in November.